Literature DB >> 21610681

Chronic kidney disease: Association between ESA use and stroke in patients with CKD.

Lynda Szczech.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21610681     DOI： 10.1038/nrneph.2011.70

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  7 in total

1.  Erythropoietic response and outcomes in kidney disease and type 2 diabetes.

Authors:  Scott D Solomon; Hajime Uno; Eldrin F Lewis; Kai-Uwe Eckardt; Julie Lin; Emmanuel A Burdmann; Dick de Zeeuw; Peter Ivanovich; Andrew S Levey; Patrick Parfrey; Giuseppe Remuzzi; Ajay K Singh; Robert Toto; Fannie Huang; Jerome Rossert; John J V McMurray; Marc A Pfeffer
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

2.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

3.  Erythropoiesis-stimulating agents increase the risk of acute stroke in patients with chronic kidney disease.

Authors:  Stephen L Seliger; Amy D Zhang; Matthew R Weir; Loreen Walker; Van Doren Hsu; Afshin Parsa; Clarissa J Diamantidis; Jeffrey C Fink
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

4.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

Authors:  A Besarab; W K Bolton; J K Browne; J C Egrie; A R Nissenson; D M Okamoto; S J Schwab; D A Goodkin
Journal:  N Engl J Med       Date:  1998-08-27       Impact factor: 91.245

5.  A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.

Authors:  Marc A Pfeffer; Emmanuel A Burdmann; Chao-Yin Chen; Mark E Cooper; Dick de Zeeuw; Kai-Uwe Eckardt; Jan M Feyzi; Peter Ivanovich; Reshma Kewalramani; Andrew S Levey; Eldrin F Lewis; Janet B McGill; John J V McMurray; Patrick Parfrey; Hans-Henrik Parving; Giuseppe Remuzzi; Ajay K Singh; Scott D Solomon; Robert Toto
Journal:  N Engl J Med       Date:  2009-10-30       Impact factor: 91.245

6.  Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Authors:  Lynda A Szczech; Huiman X Barnhart; Jula K Inrig; Donal N Reddan; Shelly Sapp; Robert M Califf; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

7.  A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment.

Authors:  Lynda A Szczech; Huiman X Barnhart; Shelly Sapp; G Michael Felker; Adrian Hernandez; Donal Reddan; Robert M Califf; Jula K Inrig; Uptal D Patel; Ajay K Singh
Journal:  Kidney Int       Date:  2009-11-04       Impact factor: 10.612
  7 in total
  1 in total

1.  Long-term safety and efficacy of ferric citrate in phosphate-lowering and iron-repletion effects among patients with on hemodialysis: A multicenter, open-label, Phase IV trial.

Authors:  Chien-Te Lee; Chin-Chan Lee; Ming-Ju Wu; Yi-Wen Chiu; Jyh-Gang Leu; Ming-Shiou Wu; Yu-Sen Peng; Mai-Szu Wu; Der-Cherng Tarng
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.